发明名称 NITROGENATED HETEROCYCLIC DERIVATIVE, AND PHARMACEUTICAL AGENT COMPRISING THE DERIVATIVE AS ACTIVE INGREDIENT.
摘要 <p>Disclosed is a compound represented by the general formula (I), a salt or N-oxide of the compound, a solvate of the compound, salt or N-oxide, or a prodrug of the compound, salt, N-oxide or solvate, which can bind specifically to CCR5 and therefore is useful for the prevention and/or treatment of a CCR5-associated disease, such as an inflammatory disease (e.g., asthma, nephritis, nephropathia, hepatitis, arthritis, rheumatoid arthritis, rhinitis, conjunctivitis, ulcerative colitis), an immune-mediated disease (e.g., autoimmune disease, rejection after organ transplantation, immunosuppression, psoriasis, multiple sclerosis), an infectious disease (e.g., infection with human immunodeficiency virus, acquired immunodeficiency syndrome), an allergic disease (e.g., atopic dermatitis, urticaria, allergic bronchopulmonary aspergillosis, allergic eosinophilic gastroenteritis), suppression of ischemia-reperfusion injury, acute respiratory syndrome, shock associated with a bacterial infection, diabetes, cancer metastasis or the like. (I) wherein each symbol is as defined in the description.</p>
申请公布号 MX2008011414(A) 申请公布日期 2008.09.22
申请号 MX20080011414 申请日期 2007.03.09
申请人 ONO PHARMACEUTICAL CO., LTD. 发明人 SHIRO SHIBAYAMA.;SHINYA KUSUDA;TOSHIHIKO NISHIYAMA;KAZUYA HASHIMURA;JUNYA UEDA
分类号 C07D401/12;A61K31/4545;A61K31/496;A61K31/5377;A61K31/549;A61K31/554;A61P1/04;A61P1/16;A61P9/00;A61P11/02;A61P11/06;A61P13/12;A61P17/06;A61P19/02;A61P25/00;A61P27/02;A61P29/00;A61P31/00;A61P31/12;A61P31/18;A61P37/00;A61P37/06;A61P37/08;A61P43/00;C07D401/14;C07D417/14;C07D419/14 主分类号 C07D401/12
代理机构 代理人
主权项
地址